54.754063, 25.262225
PDF / print export
Biotechpharma (Northway)
Vilnius, Lithuania
- Verified lead
- Vladas Algirdas Bumelis
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO, Executive Chairman of the Board and Advisory Board
- 2026 technical specialization
- Cell Line Dev
- Review cycle
- May 2026
- Full address
- Mokslininku str. 4, LT-08412 Vilnius, Lithuania
- Site coordinates
- 54.754063, 25.262225
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Northway Biotech EU management page confirming Vladas Algirdas Bumelis in the top executive role.
- Editorial note
- The historical Biotechpharma node is now tied to Northway's current management and facilities surface and remains under Vladas Bumelis' executive control.
Cell Line Dev
GMP Certified
The historical Biotechpharma node is now tied to Northway's current management and facilities surface and remains under Vladas Bumelis' executive control.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
The historical Biotechpharma node is now tied to Northway's current management and facilities surface and remains under Vladas Bumelis' executive control.
- Lead
- Vladas Algirdas Bumelis (verified ↗)
- Address
- Mokslininku str. 4, LT-08412 Vilnius, Lithuania (source ↗)
- Compliance
- GMP Certified
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Commercial CDMO
- Capabilities
- Downstream processing · Method validation · Stability studies
- Founded
- 2004
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Vladas Algirdas Bumelis
CEO, Executive Chairman of the Board and Advisory Board
Full addressMokslininku str. 4, LT-08412 Vilnius, Lithuania
Site coordinates54.754063, 25.262225
Review cycleMay 2026
Physical site source
Official Northway Biotech Europe facilities page listing Mokslininku str. 4, Vilnius.
Open sourceCommercial CDMO
Vilnius, Lithuania. Cell Line Dev. Review completed on 14 Mar 2026.
EMA
GMP Certified
Cell Line Dev
The historical Biotechpharma node is now tied to Northway's current management and facilities surface and remains under Vladas Bumelis' executive control.
Editorial note
The historical Biotechpharma node is now tied to Northway's current management and facilities surface and remains under Vladas Bumelis' executive control.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Downstream processing
Method validation
Stability studies
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Stainless steel bioreactors
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Biotechpharma (Northway) located?
- Biotechpharma (Northway) operates from Mokslininku str. 4, LT-08412 Vilnius, Lithuania, Vilnius, Lithuania.
- Who runs Biotechpharma (Northway)?
- Biotechpharma (Northway) is led by Vladas Algirdas Bumelis, CEO, Executive Chairman of the Board and Advisory Board. Verified 14 Mar 2026.
- What certifications does Biotechpharma (Northway) hold?
- Biotechpharma (Northway) is documented under GMP Certified.
- What does Biotechpharma (Northway) do?
- The historical Biotechpharma node is now tied to Northway's current management and facilities surface and remains under Vladas Bumelis' executive control. Core capabilities: Downstream processing, Method validation, Stability studies.
Editorial context
Related technical briefs
Briefs that name Vilnius as a covered market or city.